from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3898c/-

LFCtreatmentdescriptionclass of inhibitor

2.666

Amikacinug/mL Amikacintranslation

2.500

Cap5-10ug/mL Capreomycintranslation

2.676

Rox10-50 ug/mL Roxithromycintranslation

0.085

SM2-5 ug/mL Streptomycintranslation

4.250

Tet5-10 ug/mL Tetracyclinetranslation

-1.138

Rif0.2-5ug/mL Rifampicintranscription

-1.123

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.691

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.317

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.313

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.054

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.443

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.230

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.355

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.682

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.493

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.504

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.273

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.278

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.502

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.847

KCN5-20 ug/mL Potassium cyaniderespiration

-0.499

NaN30.2-2 mM Sodium aziderespiration

0.763

Nigericin50 uM Nigericinrespiration

-0.579

TRC10-150 ug/mL Triclosanrespiration

1.679

TRZ10-25 ug/mL Thioridazinerespiration

0.777

Valinomycin0.5-10 uM Valinomycinrespiration

-0.821

ZnSO42 mM ZnSO4respiration

0.238

menadione6-10 ug/mL Menadionerespiration

-0.433

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.063

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.129

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.068

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.229

NRP_1Non-replicating persistence stage 1dosRassociated

0.021

Amp0.2mg/mL AmpicillincellWall

-0.317

Cephalexin20-100 ug/mL CephalexincellWall

0.130

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.785

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.607

EMB10-20 ug/mL EthambutolcellWall

0.043

Eta12-40 ug/mL EthionamidecellWall

-0.194

INH0.2-0.4 ug/mL IsoniazidcellWall

0.037

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.224

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.225

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.139

BZA0.12 mg/mL BenzamidearomaticAmides

0.093

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.608

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.112

H2O24 mM hydrogen peroxideDNAdamaging

-0.151

Levo10 ug/mL LevofloxacinDNAdamaging

-0.040

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.180

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.806

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.177

UVUV-irradiationDNAdamaging

-0.658

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.380

Antimycin12.5-50 ug/mL Antimycin A?

-0.340

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.353

PA_110-50 ug/mL Antitubercular compound PA-1?

0.113

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.924

PA8240.2-2 ug/mL PA-824?

-0.717

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.950

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.210

Verapamil50 uM Verapamil?

0.463

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.574

methoxatin10-20 ug/mL Methoxatin?